159 related articles for article (PubMed ID: 28595944)
21. Tryptophan-kynurenine metabolism: a link between the gut and brain for depression in inflammatory bowel disease.
Chen LM; Bao CH; Wu Y; Liang SH; Wang D; Wu LY; Huang Y; Liu HR; Wu HG
J Neuroinflammation; 2021 Jun; 18(1):135. PubMed ID: 34127024
[TBL] [Abstract][Full Text] [Related]
22. Microbiome and tryptophan metabolomics analysis in adolescent depression: roles of the gut microbiota in the regulation of tryptophan-derived neurotransmitters and behaviors in human and mice.
Zhou M; Fan Y; Xu L; Yu Z; Wang S; Xu H; Zhang J; Zhang L; Liu W; Wu L; Yu J; Yao H; Wang J; Gao R
Microbiome; 2023 Jun; 11(1):145. PubMed ID: 37386523
[TBL] [Abstract][Full Text] [Related]
23. Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients.
Bhattacharyya S; Ahmed AT; Arnold M; Liu D; Luo C; Zhu H; Mahmoudiandehkordi S; Neavin D; Louie G; Dunlop BW; Frye MA; Wang L; Weinshilboum RM; Krishnan RR; Rush AJ; Kaddurah-Daouk R
Transl Psychiatry; 2019 Jul; 9(1):173. PubMed ID: 31273200
[TBL] [Abstract][Full Text] [Related]
24. Chronic unpredictable mild stress-induced behavioral changes are coupled with dopaminergic hyperfunction and serotonergic hypofunction in mouse models of depression.
Lu Q; Mouri A; Yang Y; Kunisawa K; Teshigawara T; Hirakawa M; Mori Y; Yamamoto Y; Libo Z; Nabeshima T; Saito K
Behav Brain Res; 2019 Oct; 372():112053. PubMed ID: 31288060
[TBL] [Abstract][Full Text] [Related]
25. Autophagy inhibition plays a protective role against 3, 4-methylenedioxymethamphetamine (MDMA)-induced loss of serotonin transporters and depressive-like behaviors in rats.
Shih JH; Chiu CH; Ma KH; Huang YS; Shiue CY; Yeh TY; Kao LT; Lin YY; Li IH
Pharmacol Res; 2019 Apr; 142():283-293. PubMed ID: 30826457
[TBL] [Abstract][Full Text] [Related]
26. Disease burden and government spending on mental, neurological, and substance use disorders, and self-harm: cross-sectional, ecological study of health system response in the Americas.
Vigo DV; Kestel D; Pendakur K; Thornicroft G; Atun R
Lancet Public Health; 2019 Feb; 4(2):e89-e96. PubMed ID: 30446416
[TBL] [Abstract][Full Text] [Related]
27. CircDYM ameliorates depressive-like behavior by targeting miR-9 to regulate microglial activation via HSP90 ubiquitination.
Zhang Y; Du L; Bai Y; Han B; He C; Gong L; Huang R; Shen L; Chao J; Liu P; Zhang H; Zhang H; Gu L; Li J; Hu G; Xie C; Zhang Z; Yao H
Mol Psychiatry; 2020 Jun; 25(6):1175-1190. PubMed ID: 30413800
[TBL] [Abstract][Full Text] [Related]
28. Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression.
Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Li M; Ning Y
Brain Behav Immun; 2018 Nov; 74():205-212. PubMed ID: 30213652
[TBL] [Abstract][Full Text] [Related]
29. The Phosphodiesterase Inhibitor Pentoxifylline as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial.
El-Haggar SM; Eissa MA; Mostafa TM; El-Attar KS; Abdallah MS
Psychother Psychosom; 2018; 87(6):331-339. PubMed ID: 30205379
[TBL] [Abstract][Full Text] [Related]
30. Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health.
Laurans L; Venteclef N; Haddad Y; Chajadine M; Alzaid F; Metghalchi S; Sovran B; Denis RGP; Dairou J; Cardellini M; Moreno-Navarrete JM; Straub M; Jegou S; McQuitty C; Viel T; Esposito B; Tavitian B; Callebert J; Luquet SH; Federici M; Fernandez-Real JM; Burcelin R; Launay JM; Tedgui A; Mallat Z; Sokol H; Taleb S
Nat Med; 2018 Aug; 24(8):1113-1120. PubMed ID: 29942089
[TBL] [Abstract][Full Text] [Related]
31. The Bidirectional Relationship of Depression and Inflammation: Double Trouble.
Beurel E; Toups M; Nemeroff CB
Neuron; 2020 Jul; 107(2):234-256. PubMed ID: 32553197
[TBL] [Abstract][Full Text] [Related]
32. Life Experience Matters: Enrichment and Stress Can Influence the Likelihood of Developing Alzheimer's Disease via Gut Microbiome.
Torraville SE; Flynn CM; Kendall TL; Yuan Q
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509523
[TBL] [Abstract][Full Text] [Related]
33. Cinnamon oil solid self-microemulsion mediates chronic mild stress-induced depression in mice by modulating monoamine neurotransmitters, corticosterone, inflammation cytokines, and intestinal flora.
Ma T; Tang B; Wang Y; Shen M; Ping Y; Wang L; Su J
Heliyon; 2023 Jun; 9(6):e17125. PubMed ID: 37416658
[TBL] [Abstract][Full Text] [Related]
34. HMGB1 in depression: An overview of microglial HMBG1 in the pathogenesis of depression.
Huang X; Wang B; Yang J; Lian YJ; Yu HZ; Wang YX
Brain Behav Immun Health; 2023 Jul; 30():100641. PubMed ID: 37288063
[TBL] [Abstract][Full Text] [Related]
35. DSS-induced colitis activates the kynurenine pathway in serum and brain by affecting IDO-1 and gut microbiota.
Zhao LP; Wu J; Quan W; Zhou Y; Hong H; Niu GY; Li T; Huang SB; Qiao CM; Zhao WJ; Cui C; Shen YQ
Front Immunol; 2022; 13():1089200. PubMed ID: 36776388
[TBL] [Abstract][Full Text] [Related]
36. Antidepressant-like effect of ginsenoside Rb1 on potentiating synaptic plasticity via the miR-134-mediated BDNF signaling pathway in a mouse model of chronic stress-induced depression.
Wang G; An T; Lei C; Zhu X; Yang L; Zhang L; Zhang R
J Ginseng Res; 2022 May; 46(3):376-386. PubMed ID: 35600767
[TBL] [Abstract][Full Text] [Related]
37. Blockade of Indoleamine 2, 3-dioxygenase 1 ameliorates hippocampal neurogenesis and BOLD-fMRI signals in chronic stress precipitated depression.
Gao L; Gao T; Zeng T; Huang P; Wong NK; Dong Z; Li Y; Deng G; Wu Z; Lv Z
Aging (Albany NY); 2021 Feb; 13(4):5875-5891. PubMed ID: 33591947
[TBL] [Abstract][Full Text] [Related]
38. Gut microbiota, kynurenine pathway and mental disorders - Review.
Więdłocha M; Marcinowicz P; Janoska-Jaździk M; Szulc A
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110145. PubMed ID: 33203568
[TBL] [Abstract][Full Text] [Related]
39. Limitations and Off-Target Effects of Tryptophan-Related IDO Inhibitors in Cancer Treatment.
Günther J; Däbritz J; Wirthgen E
Front Immunol; 2019; 10():1801. PubMed ID: 31417567
[TBL] [Abstract][Full Text] [Related]
40. Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders.
Aldrich SL; Poweleit EA; Prows CA; Martin LJ; Strawn JR; Ramsey LB
Front Pharmacol; 2019; 10():99. PubMed ID: 30837874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]